1. Academic Validation
  2. Polygalasaponin F alleviates cerebral ischemia-reperfusion injury through inhibiting mitophagy

Polygalasaponin F alleviates cerebral ischemia-reperfusion injury through inhibiting mitophagy

  • Metab Brain Dis. 2025 Oct 24;40(8):296. doi: 10.1007/s11011-025-01734-3.
Siqi Quan # 1 2 Roujia Guo # 1 2 Jingjing Bu 1 2 Nuo Wang 1 3 Yapeng Jia 1 3 Jiahui Wang 1 2 Ming Bai 1 4 Erping Xu 1 4 Xiangli Yan 5 6 Yucheng Li 7 8
Affiliations

Affiliations

  • 1 Collaborative Innovation Center of Research and Development on the Whole Industry Chain of Yu-Yao in Henan Province, Henan University of Chinese Medicine, Zhengzhou, 450046, China.
  • 2 College of Pharmacy, Henan University of Chinese Medicine, Zhengzhou, 450046, China.
  • 3 College of Materia Medica, Henan University of Chinese Medicine, Zhengzhou, 450046, China.
  • 4 Academy of Chinese Medical Sciences, Henan University of Chinese Medicine, Zhengzhou, 450046, China.
  • 5 Collaborative Innovation Center of Research and Development on the Whole Industry Chain of Yu-Yao in Henan Province, Henan University of Chinese Medicine, Zhengzhou, 450046, China. [email protected].
  • 6 Academy of Chinese Medical Sciences, Henan University of Chinese Medicine, Zhengzhou, 450046, China. [email protected].
  • 7 Collaborative Innovation Center of Research and Development on the Whole Industry Chain of Yu-Yao in Henan Province, Henan University of Chinese Medicine, Zhengzhou, 450046, China. [email protected].
  • 8 Academy of Chinese Medical Sciences, Henan University of Chinese Medicine, Zhengzhou, 450046, China. [email protected].
  • # Contributed equally.
Abstract

Neurological recovery after ischemic stroke (IS) remains clinically challenging, primarily due to cerebral ischemia-reperfusion injury (CIRI). Oxidative stress contributes to the pathogenesis of CIRI by causing Reactive Oxygen Species excessive accumulation, which disrupts mitochondrial function. Mitophagy maintains mitochondrial function by eliminating damaged or dysfunctional mitochondria. Nevertheless, Mitophagy exerts dual effects, either excessive or insufficient activation exacerbates mitochondrial dysfunction. Polygalasaponin F (PGSF), a natural triterpenoid saponin, has been demonstrated to regulate mitochondrial function. Therefore, in this study, we investigated whether PGSF protects against CIRI through inhibiting the Mitophagy in vitro and in vivo. Results showed that PGSF attenuated Apoptosis both in vivo and in vitro. Moreover, PGSF preserved mitochondrial membrane potential (MMP), reduced mitochondrial Reactive Oxygen Species (mtROS), and ameliorated mitochondrial morphology to improve mitochondrial function in vitro. Furthermore, we revealed that PGSF ameliorates CIRI via modulation of Mitophagy, evidenced by a reduced LC3II/LC3I ratio, decreased colocalization of LC3 with mitochondria, while enhancing the levels of TOM20 and p62. In conclusion, our findings imply that PGSF alleviates CIRI through inhibiting Mitophagy and reducing Apoptosis, demonstrating its therapeutic potential.

Keywords

Cerebral ischemia-reperfusion injury; Ischemic stroke; Mitophagy; Neuroprotection; Polygalasaponin F.

Figures
Products